Nomura Holdings’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-1,568,692
Closed -$4.95M 1281
2020
Q3
$4.95M Buy
1,568,692
+156,246
+11% +$493K 0.01% 280
2020
Q2
$4.14M Buy
1,412,446
+361,008
+34% +$1.06M 0.01% 249
2020
Q1
$2.96M Sell
1,051,438
-21,339
-2% -$60.2K 0.01% 212
2019
Q4
$3.48M Buy
1,072,777
+249,472
+30% +$809K 0.01% 282
2019
Q3
$1.76M Sell
823,305
-152,706
-16% -$326K 0.01% 369
2019
Q2
$2.99M Buy
976,011
+26,525
+3% +$81.3K 0.01% 337
2019
Q1
$3.53M Buy
949,486
+32,539
+4% +$121K 0.01% 322
2018
Q4
$2.65M Buy
916,947
+44,944
+5% +$130K 0.01% 382
2018
Q3
$2.22M Buy
872,003
+22,752
+3% +$57.9K 0.01% 417
2018
Q2
$1.99M Hold
849,251
0.01% 425
2018
Q1
$2.5K Buy
849,251
+22,925
+3% +$67 ﹤0.01% 468
2017
Q4
$2.27M Buy
826,326
+28,192
+4% +$77.6K ﹤0.01% 453
2017
Q3
$2.7M Buy
798,134
+20,721
+3% +$70.2K 0.01% 409
2017
Q2
$1.93M Buy
777,413
+17,073
+2% +$42.3K ﹤0.01% 512
2017
Q1
$1.72M Buy
+760,340
New +$1.72M ﹤0.01% 367
2016
Q2
Sell
-39,109
Closed -$129K 1375
2016
Q1
$129K Sell
39,109
-48,051
-55% -$158K ﹤0.01% 971
2015
Q4
$310K Buy
87,160
+24,196
+38% +$86.1K ﹤0.01% 863
2015
Q3
$340K Sell
62,964
-20,556
-25% -$111K ﹤0.01% 758
2015
Q2
$557K Buy
83,520
+69,819
+510% +$466K ﹤0.01% 906
2015
Q1
$99K Sell
13,701
-171,482
-93% -$1.24M ﹤0.01% 1235
2014
Q4
$1.45M Sell
185,183
-64,867
-26% -$509K ﹤0.01% 578
2014
Q3
$1.91M Buy
250,050
+141,766
+131% +$1.08M 0.01% 553
2014
Q2
$1.04M Sell
108,284
-99,934
-48% -$963K ﹤0.01% 762
2014
Q1
$1.73M Sell
208,218
-52,189
-20% -$434K ﹤0.01% 733
2013
Q4
$2.21M Buy
260,407
+52,635
+25% +$446K 0.01% 582
2013
Q3
$1.65M Buy
207,772
+4,012
+2% +$31.9K 0.01% 810
2013
Q2
$1.57M Buy
+203,760
New +$1.57M 0.01% 710